Telstra’s woes are unlikely to be cured by a multi-billion dollar novelty cheque. To prosper, the company must use the cash injection to build a valuable and sustainable competitive advantage.
Read Roger’s article at www.eurkeareport.com.au
Telstra’s woes are unlikely to be cured by a multi-billion dollar novelty cheque. To prosper, the company must use the cash injection to build a valuable and sustainable competitive advantage.
Read Roger’s article at www.eurkeareport.com.au